Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Prepaid Assets: 2015-2024

Historic Prepaid Assets for Intellia Therapeutics (NTLA) over the last 10 years, with Dec 2024 value amounting to $29.8 million.

  • Intellia Therapeutics' Prepaid Assets rose 36.22% to $59.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.8 million, marking a year-over-year increase of 36.22%. This contributed to the annual value of $29.8 million for FY2024, which is 39.92% down from last year.
  • As of FY2024, Intellia Therapeutics' Prepaid Assets stood at $29.8 million, which was down 39.92% from $49.7 million recorded in FY2023.
  • In the past 5 years, Intellia Therapeutics' Prepaid Assets ranged from a high of $49.7 million in FY2023 and a low of $17.0 million during FY2020.
  • Over the past 3 years, Intellia Therapeutics' median Prepaid Assets value was $29.8 million (recorded in 2024), while the average stood at $33.3 million.
  • In the last 5 years, Intellia Therapeutics' Prepaid Assets spiked by 231.37% in 2020 and then plummeted by 39.92% in 2024.
  • Yearly analysis of 5 years shows Intellia Therapeutics' Prepaid Assets stood at $17.0 million in 2020, then climbed by 9.21% to $18.6 million in 2021, then rose by 9.81% to $20.4 million in 2022, then skyrocketed by 143.30% to $49.7 million in 2023, then crashed by 39.92% to $29.8 million in 2024.